JP2003528139A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003528139A5 JP2003528139A5 JP2001570257A JP2001570257A JP2003528139A5 JP 2003528139 A5 JP2003528139 A5 JP 2003528139A5 JP 2001570257 A JP2001570257 A JP 2001570257A JP 2001570257 A JP2001570257 A JP 2001570257A JP 2003528139 A5 JP2003528139 A5 JP 2003528139A5
- Authority
- JP
- Japan
- Prior art keywords
- xanthophyll
- expression
- astaxanthin
- animal
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001465754 Metazoa Species 0.000 description 5
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 4
- 102000019034 Chemokines Human genes 0.000 description 4
- 108010012236 Chemokines Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 235000013793 astaxanthin Nutrition 0.000 description 4
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 4
- 229940022405 astaxanthin Drugs 0.000 description 4
- 239000001168 astaxanthin Substances 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 4
- 229960005375 lutein Drugs 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 4
- 235000008210 xanthophylls Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 229940124788 therapeutic inhibitor Drugs 0.000 description 2
- 241000168525 Haematococcus Species 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0001071A SE0001071D0 (sv) | 2000-03-27 | 2000-03-27 | Method of inhibiting the expression of inflammatory cytokines and chemokines |
| SE0001071-0 | 2000-03-27 | ||
| PCT/SE2001/000600 WO2001072296A1 (en) | 2000-03-27 | 2001-03-21 | Method of inhibiting the expression of inflammatory cytokines and chemokines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003528139A JP2003528139A (ja) | 2003-09-24 |
| JP2003528139A5 true JP2003528139A5 (enExample) | 2008-05-15 |
Family
ID=20279020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570257A Pending JP2003528139A (ja) | 2000-03-27 | 2001-03-21 | 炎症性サイトカインおよびケモカインの発現を阻害する方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1267857B1 (enExample) |
| JP (1) | JP2003528139A (enExample) |
| AT (1) | ATE353639T1 (enExample) |
| AU (1) | AU2001242965A1 (enExample) |
| CA (1) | CA2405479C (enExample) |
| DE (1) | DE60126591D1 (enExample) |
| SE (1) | SE0001071D0 (enExample) |
| WO (1) | WO2001072296A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002349784A1 (en) * | 2001-12-03 | 2003-06-17 | Asahi Kasei Pharma Corporation | Nf-kappab activating genes |
| EP2653157B1 (en) * | 2004-02-04 | 2016-08-03 | Fuji Chemical Industry Co., Ltd. | Astaxanthin for improving muscle atrophy |
| JP2006008714A (ja) * | 2005-03-17 | 2006-01-12 | Yamaha Motor Co Ltd | マトリックスメタロプロテイナーゼ阻害剤 |
| JP2006008718A (ja) * | 2005-06-03 | 2006-01-12 | Yamaha Motor Co Ltd | シクロオキシゲナーゼ活性阻害剤 |
| JP2006008719A (ja) * | 2005-06-23 | 2006-01-12 | Yamaha Motor Co Ltd | 血中過酸化脂質抑制剤 |
| WO2008106606A2 (en) * | 2007-02-28 | 2008-09-04 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs and derivatives in the treatment of prostate cancer |
| US7805004B2 (en) * | 2007-02-28 | 2010-09-28 | Microsoft Corporation | Radical set determination for HMM based east asian character recognition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05155736A (ja) * | 1991-12-10 | 1993-06-22 | Nakano Seiyaku Kk | 化粧料 |
| JPH0799924A (ja) * | 1993-09-30 | 1995-04-18 | Nippon Suisan Kaisha Ltd | アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法 |
| JPH07300421A (ja) * | 1994-04-28 | 1995-11-14 | Itano Reitou Kk | 抗炎症剤 |
| US5527533A (en) * | 1994-10-27 | 1996-06-18 | Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
| EP0806946A2 (de) * | 1995-02-03 | 1997-11-19 | Basf Aktiengesellschaft | Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen |
| JPH09124470A (ja) * | 1995-10-26 | 1997-05-13 | Suntory Ltd | 抗ストレス組成物 |
| JPH09143063A (ja) * | 1995-11-22 | 1997-06-03 | Kose Corp | 外用に適する組成物 |
| SE522246C2 (sv) * | 1997-02-27 | 2004-01-27 | Astacarotene Ab | Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion |
| WO1998045241A2 (en) * | 1997-04-04 | 1998-10-15 | Henkel Corporation | Lutein esters having high bioavailability |
| SE512531C2 (sv) * | 1997-09-04 | 2000-03-27 | Astacarotene Ab | Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur |
-
2000
- 2000-03-27 SE SE0001071A patent/SE0001071D0/xx unknown
-
2001
- 2001-03-21 JP JP2001570257A patent/JP2003528139A/ja active Pending
- 2001-03-21 DE DE60126591T patent/DE60126591D1/de not_active Expired - Fee Related
- 2001-03-21 AU AU2001242965A patent/AU2001242965A1/en not_active Abandoned
- 2001-03-21 AT AT01916022T patent/ATE353639T1/de not_active IP Right Cessation
- 2001-03-21 WO PCT/SE2001/000600 patent/WO2001072296A1/en not_active Ceased
- 2001-03-21 CA CA2405479A patent/CA2405479C/en not_active Expired - Fee Related
- 2001-03-21 EP EP01916022A patent/EP1267857B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Damoulis et al. | Cytokines induce nitric oxide production in mouse osteoblasts | |
| ITMI20020399A1 (it) | Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici | |
| AR025247A1 (es) | Composiciones de granulos de carotenos-xantofilos, estables | |
| NO20056223L (no) | Preparat til behandling av infeksjon hos kveg og svin | |
| ATE230259T1 (de) | Verwendung von redispergierbaren polymerpulvern oder polymergranulaten als bindemittel zur herstellung von festen pharmazeutischen darreichungsformen | |
| ATE483801T1 (de) | Zellproliferationshemmer, die anti-glypican 3 antikörper enthalten | |
| AR098251A2 (es) | Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario | |
| BRPI0410467A (pt) | composições e métodos para tratamento de sìndrome respiratória aguda severa (sars) | |
| JP2003528139A5 (enExample) | ||
| PT1401415E (pt) | Utilizacao de derivados de n-fenil-2-pirimidino-amina para o tratamento de doencas inflamatorias | |
| WO2003002107A3 (en) | Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) | |
| DK1401413T3 (da) | Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme | |
| CO5611088A2 (es) | Reduccion del crecimiento del vello | |
| ATE297223T1 (de) | Teilchenförmige vitaminzubereitung | |
| WO2004069173A3 (en) | Methods for modulating an inflammatory response | |
| DE60227701D1 (de) | Die verwendung von c-kithemmern zur förderung des haarwuchses | |
| DE69703820D1 (de) | Diaromatische propynyl- oder dienylverbindungen | |
| AR043418A1 (es) | Formulaciones liquidas de las proteinas de union del factor necrosis del tumor | |
| PT1330244E (pt) | Composições compreendendo compostos de modafinil | |
| SE9704590D0 (sv) | Method of increasing the production and improving the quality of semen | |
| CR7515A (es) | Composicion veterinaria inyectable para animales pequenos | |
| SE0001071D0 (sv) | Method of inhibiting the expression of inflammatory cytokines and chemokines | |
| WO2001080891A8 (en) | Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same | |
| AR000555A1 (es) | Uso de composiciones anabolicas para la masa osea en base a cantidades efectivas no toxicas del ácido Ä3-(n,n-dimetilamino)-1-hidroxipropilidenoÜbisfosfonico o la sal monosodica u otra sal farmacéuticamente aceptable del mismo | |
| ATE269065T1 (de) | Behandlung von verdauungsstörungen |